Medication info

Myeongmun Inopan Injection (Dopamine Hydrochloride)

Prescription medicationIntravenous injection
Ingredient · strength
Dopamine Hydrochloride›200mg / 1 ampoule
Manufacturer / importer
Myungmoon Pharmaceutical Co., Ltd.
Appearance
A brown transparent ampoule containing a colorless to pale yellow transparent liquid
Packaging
1 ampoule (5mL)*50 (For export) 1 ampoule (5mL)*10,50
Approval status
Active

MFDS item code 198401120 · Notified 1984.05.18 · Insurance code 649801421

Summary

Main use
Improves hypotension due to decreased cardiac output, shock, and decreased urine output
Who receives it
Adults
Adult administration
1. Dose Adults: Administer dopamine hydrochloride intravenously at 2-5㎍/min per kg of body weight. In severe cases, the dose may be increased from 5-10㎍/min to 20-50㎍/min per kg of body weight for intravenous administration. Adjust the dose as appropriate according to age and symptoms. 2. Before administering this drug, administer blood or plasma to achieve a venous pressure of 10-15㎝ H2O and a pulmonary wedge pressure of 14-18mmHg. 3. If administering more than 50㎍/min per kg of body weight, check urine output frequently. 4. Diluent For intravenous injection, dilute in 250㎖ or 500㎖ of one of the following solutions: normal saline, 5% dextrose injection, 5% dextrose in 0.9% normal saline, 5% dextrose dissolved in 0.45% normal saline, 5% dextrose dissolved in lactated Ringer's solution, sodium lactate injection, or lactated Ringer's solution.

Ingredients

Manufacturer
Myungmoon Pharmaceutical Co., Ltd.

Efficacy & effects

Improves hypotension due to decreased cardiac output, shock, and decreased urine output

  • Myocardial infarction
  • trauma
  • endotoxin sepsis
  • post-operative shock
  • renal shock
  • chronic heart failure shock
  • oliguria
  • anuria
  • hypotension due to decreased cardiac output
View approved original text

This medicine is used to treat shock caused by myocardial infarction, trauma, endotoxin sepsis, post-operative shock, renal function impairment, chronic heart failure (congestive heart failure), and hypotension due to oliguria, anuria, and reduced cardiac output.

How it is given

Adult administration

1. Dose Adults: Administer dopamine hydrochloride intravenously at 2-5㎍/min per kg of body weight. In severe cases, the dose may be increased from 5-10㎍/min to 20-50㎍/min per kg of body weight for intravenous administration. Adjust the dose as appropriate according to age and symptoms. 2. Before administering this drug, administer blood or plasma to achieve a venous pressure of 10-15㎝ H2O and a pulmonary wedge pressure of 14-18mmHg. 3. If administering more than 50㎍/min per kg of body weight, check urine output frequently. 4. Diluent For intravenous injection, dilute in 250㎖ or 500㎖ of one of the following solutions: normal saline, 5% dextrose injection, 5% dextrose in 0.9% normal saline, 5% dextrose dissolved in 0.45% normal saline, 5% dextrose dissolved in lactated Ringer's solution, sodium lactate injection, or lactated Ringer's solution.

Precautions

This medication may contain glass particles when opening the ampoule, so extra caution should be taken, especially when used in children or the elderly. This medication should not be used in patients with certain conditions. For example, it should not be administered to patients with pheochromocytoma, tachyarrhythmias, ventricular fibrillation, hyperthyroidism, or closed-angle glaucoma. Patients with peripheral vascular disorders or who are allergic to sulfites should use this medication cautiously. Asthma patients sensitive to sulfites require special attention. This drug can cause cardiovascular side effects such as cardiac arrhythmias, ischemia due to peripheral vascular constriction, tachycardia, angina pectoris, and palpitations, thus the patient's condition should be closely monitored during administration. Additionally, gastrointestinal side effects such as nausea, vomiting, abdominal pain, and neurological effects such as headache, anxiety, and inflammation at the injection site may also occur. Depending on the shock state, fluid, blood transfusion, and respiratory management may be necessary; if there is a deficiency in blood volume, it should be supplemented first. If the pulse decreases during administration, the dosage should be reduced and the patient should be monitored closely. This drug may interact with certain anesthetics, MAO inhibitors, and antidepressants, so caution is required when co-administered, and dosage adjustments may be necessary. Women who are pregnant or may become pregnant should only use this medication when the benefits of treatment outweigh the risks, and lactating women should avoid administration if possible or discontinue breastfeeding. Safety and efficacy in children have not been established, so it is advisable not to use in pediatric patients. In elderly patients, due to decreased bodily functions, the risk of side effects is greater, so starting with a low dose and monitoring the condition is recommended. To prevent tissue damage at the injection site, it is advisable to administer the injection into a large vein, particularly the antecubital vein, and appropriate measures should be taken in case of tissue infiltration. This medication's efficacy may be reduced when used with alkaline solutions, so it should not be diluted with alkaline solutions like 5% sodium bicarbonate and should be used within 24 hours after dilution.

Side effects

Ventricular ectopic beats, atrial fibrillation, ventricular tachycardia, peripheral vascular constriction, tachycardia, angina pectoris, palpitations, dyspnea, hypotension, abnormal conduction, bradycardia, QRS widening, hypernitrogenemia, hypertension, nausea, vomiting, abdominal distension, abdominal pain, paralytic ileus, headache, anxiety, phlebitis, necrotizing fasciitis at the injection site, lipoma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to light and should be stored in a light-protected container. It is also important to store it at room temperature, that is, in a typical indoor temperature that is not too hot or cold, to maintain the drug's efficacy.

Appearance and packaging

Appearance

A brown transparent ampoule containing a colorless to pale yellow transparent liquid

Package unit

1 ampoule (5mL)*50 (For export) 1 ampoule (5mL)*10,50

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.